Suppr超能文献

Selective and extremely long inhibition of prolactin release in man by 1-ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta- carbonyl)-urea-diphosphate (FCE 21336).

作者信息

Pontiroli A E, Viberti G C, Mangili R, Cammelli L, Dubini A

出版信息

Br J Clin Pharmacol. 1987 Apr;23(4):433-8. doi: 10.1111/j.1365-2125.1987.tb03072.x.

Abstract

The effects on anterior pituitary function of FCE 21336 (1-ethyl-3-(3'-dimethylaminopropyl)-3-(6'-allylergoline-8'-beta-ca rbonyl)-urea- diphosphate), a synthetic ergoline derivative with selective dopamine agonistic properties, were studied. Circulating PRL, GH, TSH, cortisol and LH levels were determined up to 96 h after single oral doses of 50, 100, 200 and 300 micrograms of the compound to eight healthy males, and up to 168 h after single oral doses of 400 and 600 micrograms to six healthy males, according to double-blind, within subjects, experimental designs vs placebo. Vital signs, ECG, laboratory tests and the appearance of newly observed signs and symptoms were monitored. A dose-related decrease of serum PRL in comparison with both basal and post-placebo levels was observed after 200 micrograms and greater doses of the compound, with inhibition of spontaneous circadian rhythm. Maximal inhibition (PRL less than 2 ng ml-1) was observed in one out of five subjects after 200, three out of seven subjects after 300, four out of six after 400 and five out of six subjects after 600 micrograms. The effect was of rapid onset and long duration; the maximum or nearly maximum decrease was observed within 3 h after dosing as well as up to 96 h (200 and 300 micrograms) and up to 168 h (400 and 600 micrograms). No modifications of GH, TSH, LH and cortisol as well as of vital signs, ECG and laboratory tests were apparent.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

相似文献

2
Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man.
J Clin Endocrinol Metab. 1978 Aug;47(2):372-8. doi: 10.1210/jcem-47-2-372.
3
Pergolide mesylate: its effects on circulating anterior pituitary hormones in man.
J Clin Endocrinol Metab. 1981 Oct;53(4):772-8. doi: 10.1210/jcem-53-4-772.
5
6
Hormonal effects of CQP 201-403, a new dopamine agonist.
Acta Endocrinol (Copenh). 1988 Nov;119(3):452-8. doi: 10.1530/acta.0.1190452.
8
Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man.
J Clin Endocrinol Metab. 1984 May;58(5):838-44. doi: 10.1210/jcem-58-5-838.

本文引用的文献

1
Endocrine profile and therapeutic employment of a new prolactin-lowering drug, metergoline.
Gynecol Obstet Invest. 1980;11(1):1-16. doi: 10.1159/000299801.
2
The inhibition of prolactin secretion in man by CB-154 (2-Br-alpha-ergocryptine).
J Clin Endocrinol Metab. 1972 Nov;35(5):768-71. doi: 10.1210/jcem-35-5-768.
3
Importance of aspirates in the respiratory-distress syndrome.
Lancet. 1971 Oct 2;2(7727):768. doi: 10.1016/s0140-6736(71)92134-9.
4
Pharmacologic effects in man of a potent, long-acting dopamine receptor agonist.
Science. 1979 Sep 14;205(4411):1151-3. doi: 10.1126/science.382359.
5
The effect of lisuride hydrogen maleate in the hyperprolactinaemia-amenorrhoea syndrome: clinical and hormonal responses.
Clin Endocrinol (Oxf). 1978 Dec;9(6):491-8. doi: 10.1111/j.1365-2265.1978.tb01506.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验